易普力(002096.SZ):公司在西藏佈局的2.5萬噸工業炸藥產能
格隆匯8月5日丨易普力(002096.SZ)在投資者互動平臺表示,公司在西藏佈局的2.5萬噸工業炸藥產能,是結合當地礦產資源開發規劃、安全環保要求及行業監管政策等綜合確定,並非受法規限制,該產能專項服務於巨龍銅礦項目,是基於項目實際需求的精準配置。公司始終關注西藏地區發展機遇,已在當地設立林芝分公司、組建西藏工程公司,前瞻性規劃產能配置。未來將依託全國性產能動態調控體系,通過跨區域調度靈活響應增量需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.